Zhang Xiaoyan Michelle

Chief Scientific OfficerIkena Oncology, Inc. (IKNA) · full profile →Form 4 · filed Jan 12, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$12K
Net Open-Market Flow
-$12K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 11, 2022Sell(S)964$12.00$12K44K
Jan 11, 2022Option exercise(M)964$2.15$2K45K
Jan 10, 2022Option exercise(M)36$2.15$7745K
Jan 10, 2022Sell(S)36$12.00$43244K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 11, 2022Option exercise(M)964$024K
Jan 10, 2022Option exercise(M)36$025K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-001806) within minutes of acceptance. Every field above traces to the original document. Verify it directly: